Yan Vitor Gomes Silva de Jesus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yan Vitor Gomes Silva de Jesus has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Ferreira Oliveira
Brazilian Society of Oncological Surgery, University Hospital of the Federal University of Juiz de Fora, Head of the Oncology Service Juiz de Fora Minas Gerais Brazil
3 shared publications - Carlos Eduardo Santa Ritta Barreira
Sociedade Brasileira de Cirurgia de Cabeça e Pescoço São Paulo, Brasil; Sociedade Brasileira de Cirurgia Oncológica Rio de Janeiro, Brasil
3 shared publications Elves Maciel
Adult Surgical ICU—Santa Izabel Hospital Salvador Bahia Brazil
3 shared publicationsGiovani Alves Monteiro
HU of UFJF, Department of Surgery Juiz de Fora Minas Gerais Brazil
3 shared publicationsHeladio Feitosa e Castro Neto
Ceará Cancer Institute Fortaleza Ceara Brazil
3 shared publicationsJoão Rosa de Almeida
Monte Sinai Hospital Juiz de Fora Minas Gerais Brazil
3 shared publications
Latest Publications
- Open Access
- 15 November 2026
- Published by Wiley in Journal of Surgical Oncology
Brazilian Society of Surgical Oncology Guideline for Bloodless Surgery. (Part 2: Intraoperative Strategies)
Introduction: The Brazilian Society of Surgical Oncology (SBCO) developed evidence‐informed consensus recommendations for intraoperative blood conservation and the rational use of blood components in surgical patients. Methods: Between June and December 2024, a multidisciplinary panel of 40 experts developed 48 clinical questions covering three perioperative phases: preoperative, intraoperative, and postoperative care. This second article of the series addresses 16 questions related to intraoperative blood conservation. Expert working groups conducted structured literature reviews and drafted preliminary recommendations, which were subsequently reviewed by the project coordinators and submitted to an online consensus vote. Because high‐quality oncology‐specific evidence was limited for some questions, evidence from other surgical populations was considered when clinically applicable, with indirectness reflected in the wording and grading of the recommendations. An adapted evidence‐classification system was used to determine the level of evidence and grade of recommendation. Conclusion: Intraoperative blood conservation requires an individualized, multimodal, and multidisciplinary approach. The selection of anesthetic, pharmacological, surgical, and blood‐conservation interventions should consider the quality and directness of the available evidence, patient characteristics, surgical complexity, expected blood loss, and patient preferences.
- 15 November 2026
- Published by Wiley in Journal of Surgical Oncology
Open AccessBrazilian Society of Surgical Oncology Guideline for Bloodless Surgery. (Part 2: Intraoperative Strategies)
Introduction: The Brazilian Society of Surgical Oncology (SBCO) developed evidence‐informed consensus recommendations for intraoperative blood conservation and the rational use of blood components in surgical patients. Methods: Between June and December 2024, a multidisciplinary panel of 40 experts developed 48 clinical questions covering three perioperative phases: preoperative, intraoperative, and postoperative care. This second article of the series addresses 16 questions related to intraoperative blood conservation. Expert working groups conducted structured literature reviews and drafted preliminary recommendations, which were subsequently reviewed by the project coordinators and submitted to an online consensus vote. Because high‐quality oncology‐specific evidence was limited for some questions, evidence from other surgical populations was considered when clinically applicable, with indirectness reflected in the wording and grading of the recommendations. An adapted evidence‐classification system was used to determine the level of evidence and grade of recommendation. Conclusion: Intraoperative blood conservation requires an individualized, multimodal, and multidisciplinary approach. The selection of anesthetic, pharmacological, surgical, and blood‐conservation interventions should consider the quality and directness of the available evidence, patient characteristics, surgical complexity, expected blood loss, and patient preferences.
- 30 September 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 134 (6) , 805-813
Brazilian Society of Surgical Oncology Guideline for Bloodless Surgery (Part 3: Postoperative Strategies)
Objective: To present postoperative strategies for bloodless surgery in oncologic patients, focusing on anemia management, bleeding control, oxygen delivery, and recovery without allogeneic blood transfusion. Methods: The Brazilian Society of Oncologic Surgery developed national recommendations for the rational use of blood products in surgical care. Between June and December 2024, a multidisciplinary panel of specialists reviewed the literature and formulated key questions covering preoperative, intraoperative, and postoperative management. Recommendations were graded using an adapted evidence classification system and validated through expert consensus. Results: Postoperative bloodless care should prioritize judicious laboratory testing to reduce iatrogenic anemia, targeted iron replacement, selective use of erythropoiesis‐stimulating agents, individualized hemostatic therapy, early recognition and control of hemorrhage, and optimization of oxygen delivery. General postoperative measures, including mobilization, analgesia, infection prevention, rehabilitation, and discharge planning, should be retained when directly related to anemia tolerance, blood conservation, or recovery in patients managed without transfusion. Conclusion: Postoperative bloodless surgery requires coordinated multidisciplinary care, early bleeding control, anemia treatment, oxygen delivery optimization, and careful follow‐up. These strategies may improve safety and recovery in oncologic patients who decline or require avoidance of allogeneic blood transfusion.
- 30 September 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 134 (6) , 805-813
Brazilian Society of Surgical Oncology Guideline for Bloodless Surgery (Part 3: Postoperative Strategies)
Objective: To present postoperative strategies for bloodless surgery in oncologic patients, focusing on anemia management, bleeding control, oxygen delivery, and recovery without allogeneic blood transfusion. Methods: The Brazilian Society of Oncologic Surgery developed national recommendations for the rational use of blood products in surgical care. Between June and December 2024, a multidisciplinary panel of specialists reviewed the literature and formulated key questions covering preoperative, intraoperative, and postoperative management. Recommendations were graded using an adapted evidence classification system and validated through expert consensus. Results: Postoperative bloodless care should prioritize judicious laboratory testing to reduce iatrogenic anemia, targeted iron replacement, selective use of erythropoiesis‐stimulating agents, individualized hemostatic therapy, early recognition and control of hemorrhage, and optimization of oxygen delivery. General postoperative measures, including mobilization, analgesia, infection prevention, rehabilitation, and discharge planning, should be retained when directly related to anemia tolerance, blood conservation, or recovery in patients managed without transfusion. Conclusion: Postoperative bloodless surgery requires coordinated multidisciplinary care, early bleeding control, anemia treatment, oxygen delivery optimization, and careful follow‐up. These strategies may improve safety and recovery in oncologic patients who decline or require avoidance of allogeneic blood transfusion.
- 12 July 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 134 (4) , 594-603
Brazilian Society of Oncologic Surgery Guideline for Bloodless Surgery (Part 1: Preoperative Strategies)
Introduction: The Brazilian Society of Surgical Oncology (SBCO) developed national guidelines for the rational use of blood concentrates in surgical procedures. Methods: Between June and December 2024, a multidisciplinary team of 42 experts formulated 48 key questions on the rational use of blood concentrates in surgery. The guidelines were structured in three phases: preoperative, intraoperative, and postoperative. Expert groups performed literature reviews and proposed preliminary recommendations, which were later refined by the coordinators. An adapted grading system was used to assess the level of evidence, and an online voting process determined consensus among experts. Conclusion: Implementing a bloodless surgery protocol requires a meticulous and coordinated approach across multiple medical disciplines. Essential elements for success include patient and staff education, comprehensive preparation, and the use of advanced surgical techniques and technologies to optimize outcomes.
- 12 July 2026
- Published by Wiley in Journal of Surgical Oncology
- Vol. 134 (4) , 594-603
Brazilian Society of Oncologic Surgery Guideline for Bloodless Surgery (Part 1: Preoperative Strategies)
Introduction: The Brazilian Society of Surgical Oncology (SBCO) developed national guidelines for the rational use of blood concentrates in surgical procedures. Methods: Between June and December 2024, a multidisciplinary team of 42 experts formulated 48 key questions on the rational use of blood concentrates in surgery. The guidelines were structured in three phases: preoperative, intraoperative, and postoperative. Expert groups performed literature reviews and proposed preliminary recommendations, which were later refined by the coordinators. An adapted grading system was used to assess the level of evidence, and an online voting process determined consensus among experts. Conclusion: Implementing a bloodless surgery protocol requires a meticulous and coordinated approach across multiple medical disciplines. Essential elements for success include patient and staff education, comprehensive preparation, and the use of advanced surgical techniques and technologies to optimize outcomes.
- 31 October 2024
- Published by Revista ft Ltda in Revista ft
- Vol. 28 (139) , 43-44
HIPOCALCEMIA NO TRAUMA, SUA INTER-RELAÇÃO COM A TRANSFUSÃO DE HEMODERIVADOS E SUA APLICABILIDADE ENQUANTO PREDITOR DE MORTALIDADE - UMA REVISÃO INTEGRATIVA
O trauma quase sempre esteve entre as principais causas de morte no Brasil e no mundo, porém sua fisiopatologia segue suscitando dúvidas até os dias atuais. Ao analisar retrospectivamente prontuários de pacientes internados em unidades de terapia intensiva, os níveis séricos reduzidos de cálcio chamaram atenção de alguns pesquisadores por sua possível inter-relação com as taxas de mortalidade e transfusão de hemoderivados, o que nos leva a questionar não somente seu papel no organismo, mas também se um possível manejo do íon seria modificador de desfecho. Dessa forma, a presente revisão tem o intuito de reunir o que há de mais atual e consistente entre os estudos a respeito da hipocalcemia no trauma de modo a tornar mais clara sua interferência na sobrevida dos pacientes e até reiterar novos questionamentos para que possam ser aprofundados por estudos posteriores.
- 31 October 2024
- Published by Revista ft Ltda in Revista ft
- Vol. 28 (139) , 43-44
HIPOCALCEMIA NO TRAUMA, SUA INTER-RELAÇÃO COM A TRANSFUSÃO DE HEMODERIVADOS E SUA APLICABILIDADE ENQUANTO PREDITOR DE MORTALIDADE - UMA REVISÃO INTEGRATIVA
O trauma quase sempre esteve entre as principais causas de morte no Brasil e no mundo, porém sua fisiopatologia segue suscitando dúvidas até os dias atuais. Ao analisar retrospectivamente prontuários de pacientes internados em unidades de terapia intensiva, os níveis séricos reduzidos de cálcio chamaram atenção de alguns pesquisadores por sua possível inter-relação com as taxas de mortalidade e transfusão de hemoderivados, o que nos leva a questionar não somente seu papel no organismo, mas também se um possível manejo do íon seria modificador de desfecho. Dessa forma, a presente revisão tem o intuito de reunir o que há de mais atual e consistente entre os estudos a respeito da hipocalcemia no trauma de modo a tornar mais clara sua interferência na sobrevida dos pacientes e até reiterar novos questionamentos para que possam ser aprofundados por estudos posteriores.
- Open Access
- 18 December 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (17)
Impacto da pandemia de COVID-19 na assistência aos pacientes com infarto agudo do miocárdio
Introduction: The pandemic triggered by SARS-CoV-2 brought challenges to the care of patients with AMI, affecting adequate care. In this study, the objective was to carry out an integrative review to analyze the impact of the COVID-19 pandemic on the delay of care for patients with AMI and, consequently, on their prognosis. Methodology: This is an integrative, qualitative literature review with a descriptive approach. A survey of articles was carried out in the main databases using the descriptors “COVID-19”, “Myocardial Infarction” and “STEMI”; and the Boolean operator AND. The inclusion criteria were: original article, available in full for free access, published in 2020 and 2021, in Portuguese, English and/or Spanish. The final sample consisted of 32 articles. Results: Retrospective cohort, retrospective observational study and meta-analyses were used in the article. These studies reported an almost 80% reduction in the admission of patients with AMI. The prognosis was worse during the pandemic period with an increase in the number of complications and an increase in morbidity and mortality. Mortality from AMI increased by 1.3% to 80% in the period of the pandemic when compared to the same period in the previous year pre-pandemic. In addition, some studies found that the mortality of patients with AMI and COVID-19 could increase by up to four times when compared to the patient with COVID alone. Conclusion: There is a reduction in admissions of AMI cases that may be linked to the fear of contamination and social isolation measures that, associated with the overload of the health system, have led to a delay in seeking care.
- 18 December 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (17)
Open AccessImpacto da pandemia de COVID-19 na assistência aos pacientes com infarto agudo do miocárdio
Introduction: The pandemic triggered by SARS-CoV-2 brought challenges to the care of patients with AMI, affecting adequate care. In this study, the objective was to carry out an integrative review to analyze the impact of the COVID-19 pandemic on the delay of care for patients with AMI and, consequently, on their prognosis. Methodology: This is an integrative, qualitative literature review with a descriptive approach. A survey of articles was carried out in the main databases using the descriptors “COVID-19”, “Myocardial Infarction” and “STEMI”; and the Boolean operator AND. The inclusion criteria were: original article, available in full for free access, published in 2020 and 2021, in Portuguese, English and/or Spanish. The final sample consisted of 32 articles. Results: Retrospective cohort, retrospective observational study and meta-analyses were used in the article. These studies reported an almost 80% reduction in the admission of patients with AMI. The prognosis was worse during the pandemic period with an increase in the number of complications and an increase in morbidity and mortality. Mortality from AMI increased by 1.3% to 80% in the period of the pandemic when compared to the same period in the previous year pre-pandemic. In addition, some studies found that the mortality of patients with AMI and COVID-19 could increase by up to four times when compared to the patient with COVID alone. Conclusion: There is a reduction in admissions of AMI cases that may be linked to the fear of contamination and social isolation measures that, associated with the overload of the health system, have led to a delay in seeking care.
- Open Access
- 12 August 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (11)
Cirurgia de urgência durante a Pandemia da COVID-19
Desde 11 de março de 2020, o mundo vive uma nova pandemia do coronavírus, causada pela doença COVID-19, o que resultou em diversas mudanças no cotidiano. A preocupação de sobrecarregar o sistema de saúde e o medo de contrair o vírus podem ter levado a apresentações tardias e piores desfechos para pacientes com quadros agudos. O objetivo do estudo é identificar e relatar os efeitos da pandemia nos serviços de cirurgias de urgência. Trata-se de uma revisão integrativa da literatura, com abordagem descritiva. A pesquisa bibliográfica teve como questão norteadora “Quais os impactos da pandemia de COVID-19 nos serviços de emergência cirúrgica?”. As bases de dados utilizadas foram: SciELO, PubMed e LILACS, com base nos descritores "COVID-19" e "Serviços Médicos de Emergência", utilizando o operador booleano AND. Não houve alterações significativas em relação ao sexo e à idade. O número de atendimentos reduziu em 21%. As taxas de complicações aumentaram 48%, juntamente com a taxa de mortalidade, que aumentou 12%, e a taxa de apresentação tardia aos serviços de emergência em 37,4%. A pandemia do novo SARS-CoV 2 influenciou significativamente a assistência dos sistemas de saúde. Nesse período, houve redução dessas cirurgias e do número de eventos agudos, como traumas. Várias hipóteses têm sido postuladas para explicar esse comportamento, incluindo o isolamento social e as informações veiculadas pela mídia sobre a situação nos hospitais, o que aumenta a demora na procura por serviços de emergência e aumenta a taxa de mortalidade.
- 12 August 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (11)
Open AccessCirurgia de urgência durante a Pandemia da COVID-19
Desde 11 de março de 2020, o mundo vive uma nova pandemia do coronavírus, causada pela doença COVID-19, o que resultou em diversas mudanças no cotidiano. A preocupação de sobrecarregar o sistema de saúde e o medo de contrair o vírus podem ter levado a apresentações tardias e piores desfechos para pacientes com quadros agudos. O objetivo do estudo é identificar e relatar os efeitos da pandemia nos serviços de cirurgias de urgência. Trata-se de uma revisão integrativa da literatura, com abordagem descritiva. A pesquisa bibliográfica teve como questão norteadora “Quais os impactos da pandemia de COVID-19 nos serviços de emergência cirúrgica?”. As bases de dados utilizadas foram: SciELO, PubMed e LILACS, com base nos descritores "COVID-19" e "Serviços Médicos de Emergência", utilizando o operador booleano AND. Não houve alterações significativas em relação ao sexo e à idade. O número de atendimentos reduziu em 21%. As taxas de complicações aumentaram 48%, juntamente com a taxa de mortalidade, que aumentou 12%, e a taxa de apresentação tardia aos serviços de emergência em 37,4%. A pandemia do novo SARS-CoV 2 influenciou significativamente a assistência dos sistemas de saúde. Nesse período, houve redução dessas cirurgias e do número de eventos agudos, como traumas. Várias hipóteses têm sido postuladas para explicar esse comportamento, incluindo o isolamento social e as informações veiculadas pela mídia sobre a situação nos hospitais, o que aumenta a demora na procura por serviços de emergência e aumenta a taxa de mortalidade.